PNEUMOCYSTIS JIROVECI PNEUMONIA
Clinical trials for PNEUMOCYSTIS JIROVECI PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECI PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECI PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter steroid course for severe PCP? new trial aims to find out
Disease control Not yet recruitingThis study looks at how long steroids should be given to adults with severe Pneumocystis pneumonia (PCP), a serious lung infection common in people with weakened immune systems. About 416 participants who improve within 10 days will either stop steroids early or continue for 21 d…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could steroids slash death rates from a rare pneumonia?
Disease control Not yet recruitingThis study tests whether adding corticosteroids (low or moderate dose) to standard care can reduce deaths from severe Pneumocystis pneumonia (PJP) in non-HIV patients in the ICU. PJP has a very high death rate of 60-80% in this group. The trial will compare two steroid doses agai…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 26, 2026 14:24 UTC